Policy alternatives for treatments for rare diseases
نویسندگان
چکیده
منابع مشابه
Policy alternatives for treatments for rare diseases.
CMAJ • NOVEMBER 23, 2010 • 182(17) © 2010 Canadian Medical Association or its licensors E787 The small market for drugs used to treat rare diseases often makes the drugs extremely expensive. Consequently, many pharmaceutical companies may stop manufacturing these drugs or may not initiate research and development into new therapies. Moving these drugs from bench to bedside requires a partnershi...
متن کاملPatient organization involvement and the challenge of securing access to treatments for rare diseases: report of a policy engagement workshop
PLAIN ENGLISH SUMMARY Patients with rare diseases often help to develop new treatments for their conditions. But once developed, those treatments are sometimes priced too high for many patients to access them. We became aware that this is a problem in the course of a social science research project that examines the place of rare diseases in health policy. We therefore organized a two-day works...
متن کاملInnovative research methods for studying treatments for rare diseases: methodological review
OBJECTIVE To examine methods for generating evidence on health outcomes in patients with rare diseases. DESIGN Methodological review of existing literature. SETTING PubMed, Embase, and Academic Search Premier searched for articles describing innovative approaches to randomized trial design and analysis methods and methods for conducting observational research in patients with rare diseases....
متن کاملTreatments for Parasitic Diseases Based on Rational Prescribing of Drugs according to Avicenna’s Approach
Background/Aim: Infections caused by parasitic worms are among the most common diseases in the world. Considering the parasitic infections resistant to treatment, drug side effects and the emergence of new immunological diseases, it seems more necessary to pay attention to the views and therapeutic experiences of physicians in Iranian Traditional Medicine (ITM). Methods: This is a review study...
متن کاملPOLICY PERSPECTIVES An Evaluation Framework for Funding Drugs for Rare Diseases
Objectives: For rare diseases it may be difficult to generate data from randomized trials to support funding of a drug. Enzyme replacement therapies for diseases of inherited metabolic enzyme deficiency provide an example of this dilemma. The Ontario Public Drug Programs convened the Drugs for Rare Diseases Working Group to develop a policy for assessing these drugs. Methods: The Drugs for Rare...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Medical Association Journal
سال: 2010
ISSN: 0820-3946,1488-2329
DOI: 10.1503/cmaj.081429